---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-001609"
form_type: "8-K"
ticker: "HBIO"
cik: "0001123494"
company_name: "HARVARD BIOSCIENCE INC"
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T07:35:33.883068+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# Harvard Bioscience approves 2024 cash incentive plan for CEO and CFO

## Summary
- Compensation Committee approved 2024 annual cash incentive plan on March 21, 2024.
- CEO and CFO each assigned a target award as a percentage of 2024 base salary.
- Payout ranges from 0% to 150% of target based on corporate financial objectives.

## SEC filing metadata
- accession: 0001171843-24-001609
- form_type: 8-K
- ticker: HBIO
- cik: 0001123494
- company_name: HARVARD BIOSCIENCE INC
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1123494/000117184324001609/0001171843-24-001609-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1123494/000117184324001609/f8k_032624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-001609
- JSON: https://secwatch.observer/filing/0001171843-24-001609.json
- Plain text: https://secwatch.observer/filing/0001171843-24-001609.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.